Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity

v3.8.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
Common Stock [Member]
Equity Payable [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Beginning balance, Amount at Dec. 31, 2016 $ 36,389 $ 100,862 $ 76,698,383 $ (32,999) $ (74,673,471) $ 2,129,164
Beginning balance, Shares at Dec. 31, 2016 36,388,997          
Issuance of common stock for options exercised, Amount $ 152   82,646     82,798
Issuance of common stock for options exercised, Shares 152,085          
Issuance of common stock for restricted stock awards, Amount $ 484   (484)      
Issuance of common stock for restricted stock awards, Shares 484,058          
Stock based compensation     1,130,297     1,130,297
Foreign currency translation adjustment       (32,765)   (32,765)
Net loss         (5,946,012) (5,946,012)
Ending balance, Amount at Dec. 31, 2017 $ 37,025 100,862 77,910,842 (65,764) (80,619,483) (2,636,518)
Ending balance, Shares at Dec. 31, 2017 37,025,140          
Issuance of common stock for options exercised, Amount $ 13   9,582     9,595
Issuance of common stock for options exercised, Shares 12,500          
Issuance of common stock for financing, Shares 2,018,125          
Issuance of common stock for warrant conversion, Amount $ 2,018   2,151,829     2,153,847
Issuance of common stock for warrant conversion, Shares 2,018,125          
Issuance of common stock for cashless warrant conversion, Amount $ 2   (2)      
Issuance of common stock for cashless warrant conversion, Shares 1,808          
Stock based compensation     252,843     252,843
Foreign currency translation adjustment       (12,615)   (12,615)
Net loss         (1,503,977) (1,503,977)
Ending balance, Amount at Mar. 31, 2018 $ 39,058 $ 100,862 $ 80,325,094 $ (78,379) $ (82,123,460) $ (1,736,825)
Ending balance, Shares at Mar. 31, 2018 39,057,573